If you're in the bull camp on TRIP, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at its 50-day moving average of $74.02 a share to more resistance at $75.43 a share with high volume. Look for volume on that move that hits near or above its three-month average volume of 1.82 million shares. If that breakout hits, then TRIP will set up to re-test or possibly take out its next major overhead resistance levels at $79.89 a share to its 52-week high at $82.19 a share. Any high-volume move above those levels will then give TRIP a chance to tag $85 to $90 a share.

I would avoid TRIP or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below some key near-term support levels at $71.60 to $68.11 a share with high volume. If we get that move, then TRIP will set up to re-test or possibly take out its next major support levels at $62.50 to its 200-day moving average of $60.03 a share.

To see more potential earnings short squeeze plays, check out the Earnings Short Squeeze Plays portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.

If you liked this article you might like

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Trader's Daily Notebook: Anemic Trading Would Be an Improvement